|
Trillium Medical Ventures LLC,
a bio science technology assessment firm
founded in 1998, evaluates life science intellectual property and technology
with the objective of identifying unique and valuable life science investment
and product development opportunities. Trillium has extensive experience in
the identification and analysis of biopharmaceutical and pharmaceutical
intellectual-property licensing opportunities at all stages of the drug-development
cycle, from basic research to regional and worldwide clinical development. The
Team is made up of pharmaceutically-trained life science professionals with
decades of industry experience encompassing drug discovery and product development,
life sciences start-up investing and intellectual property evaluation. The Trillium
Team’s experience in life sciences truly spans from the “research bench to the pharmacy
shelf” and allows us to provide expert services in the following areas:
|
|
|